🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07327008
Starting soon Not applicable

The Effectiveness of Telerehabilitation in Liver Transplant Patients

NCT07327008 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-02-01
Last updated
2026-01-12

Condition(s) studied

Liver TransplantationTelerehabilitation

Investigational drug(s) / intervention(s)

TelerehabilitationHome exercise

Telerehabilitation: The telerehabilitation program will include breathing, strengthening, balance, and walking exercises, with increasing intensity week by week, and stretching exercises targeting major muscles will be given during the cool-down period.

Home exercise: Patients will be given brochures on breathing, strengthening, balance and walking exercises and asked to perform them without a physiotherapist.

Study summary

Liver transplantation is defined as a surgical procedure in which a liver with tissue damage and inability to perform its functions is replaced, in whole or in part, with a healthy liver obtained from a living or deceased donor. Post-transplantation treatment includes medical treatment, physiotherapy, and rehabilitation. Physiotherapy and rehabilitation, an important component of liver transplantation management, consists of three phases: preoperative, early postoperative, and late postoperative. Telerehabilitation is currently defined as the control or monitoring of rehabilitation remotely using telecommunication-related technologies. Studies on telerehabilitation in liver transplant patients are insufficient in the literature. The aim of this study is to investigate the effect of a telerehabilitation-based exercise program applied to liver transplant patients on exercise capacity, respiratory muscle strength, peripheral muscle strength, fatigue level and quality of life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Being between 18-65 years of age and having undergone a liver transplant * Having had a liver transplant operation at least 6 months prior * Spontaneous breathing * Hemodynamic stability * Reading and writing skills * Ability to mobilize independently, ability to follow verbal and visual instructions Exclusion Criteria: * Presence of unstable cardiovascular disease * Presence of primary lung disease requiring regular bronchodilator treatment * Presence of neuromuscular disease or neurological complications * Musculoskeletal limitation/use of assistive devices * Being a multiple organ transplant recipient * Presence of orthopedic disability and functional capacity limitation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul University-Cerrahpasa, Faculty of Health Sciences, Physiotherapy and Rehabilitation Laboratory Büyükçekmece Istanbul

More Istanbul University - Cerrahpasa trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07327008 on ClinicalTrials.gov ↗ ← All trials in Turkey